NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ADGM

Adagio Medical Holdings Inc

Jul 01 • 04:00PM ET

1.35

Dollar change +0.05
Percentage change 3.85	%

Healthcare • Medical Devices • USA • NASD

Peers: BSX STXS EW LXRX NVRO CUTR BLFS CLPT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-11.04	Insider Own	1.81%	Shs Outstand	15.38M	Perf Week	6.30%
Market Cap	20.77M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	15.10M	Perf Month	19.47%
Enterprise Value	26.39M	PEG	-	EPS next Q	-	Inst Own	75.37%	Short Float	1.19%	Perf Quarter	67.72%
Income	-74.74M	P/S	35.81	EPS this Y	-	Inst Trans	64.23%	Short Ratio	0.09	Perf Half Y	27.36%
Sales	0.58M	P/B	1.67	EPS next Y	-	ROA	-295.04%	Short Interest	0.18M	Perf YTD	28.57%
Book/sh	0.81	P/C	1.60	EPS next 5Y	-	ROE	-329.16%	52W High	11.57 -88.33%	Perf Year	-88.19%
Cash/sh	0.84	P/FCF	-	EPS past 3/5Y	-143.50% -816.44%	ROIC	-243.29%	52W Low	0.62 116.00%	Perf 3Y	-86.89%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-449.39%	Volatility	11.99% 11.10%	Perf 5Y	-
Dividend TTM	-	EV/Sales	45.50	EPS Y/Y TTM	-4.40%	Oper. Margin	-5822.92%	ATR (14)	0.13	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.51	Sales Y/Y TTM	2115.38%	Profit Margin	-12975.00%	RSI (14)	62.67	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	2.89	EPS Q/Q	95.12%	SMA20	12.61%	Beta	0.11	Target Price	-
Payout	-	Debt/Eq	1.50	Sales Q/Q	-100.00%	SMA50	11.52%	Rel Volume	0.01	Prev Close	1.30
Employees	80	LT Debt/Eq	1.48	Earnings	-	SMA200	-20.10%	Avg Volume	1.99M	Price	1.35
IPO	Feb 26, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	24,503	Change	3.85%

May-15-25 04:05PM	Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM	Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM	Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM	Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM	Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
04:01PM	Loading…
Mar-17-25 04:01PM	Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
Feb-28-25 08:30AM	Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM	Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM	Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADGM

Adagio Medical Holdings Inc

Upgrade your FINVIZ experience